
    
      This is a cross-sectional, single site, cohort screening trial. The correlation between the
      measured skin fluorescence and the CACS will be determined using a design that includes
      stratification by gender, subject age and subject CAC score. This design requires a single
      patient visit to the clinical site and a single measurement on the SCOUT device.
    
  